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PractitionersAbstract Objective: The purpose of this study was to evaluate the knowledge of medical and dental
practitioners towards the dental management of patients who are on anti-coagulant and/or anti
platelet agents.
Methods: This study was conducted in different hospitals/health centers of Riyadh and AlKharj cit-
ies, Saudi Arabia. Participants included practitioners working in government and private medical
centers/hospitals. A self-administered questionnaire including details about the practitioners’ level
of education and work experience was used. Participants were asked questions regarding dental
management of patients on anticoagulant therapy and/or antiplatelet therapy. Result: A total of
650 self-administered questionnaires were distributed among dental and medical practitioners, of
which, 543 were returned complete. Most of the participants were general
92 A.H. Shah et al.(graduate) medical and dental practitioners (59.3%). 15.4% practitioners were in favor of
continuing the antiplatelet or anticoagulant medication without alteration while 6.6% were unsure
about stopping or continuing the medication. A less than half (35.3%) of the practitioners were
using current guidelines for managing such patients. Dentist (58.6%) and medical practitioners
(64.7%) felt that evidence based guidelines would be helpful in dental management of patients
on antithrombotic therapy.
Conclusion: Dentists and medical practitioners showed a wide range of approach in terms of knowl-
edge related to management of patient taking anticoagulant and/or antiplatelet medication prior to
dental treatment. There is a need to educate both medical and dental practitioners to use evidence
based guidelines for management of such patients.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Oral anticoagulants and anti-platelets drugs are widely pre-
scribed for the prevention of various medical conditions,
including thromboembolism, atrial ﬁbrillation, multiple
venous thromboembolism, congestive heart failure and artiﬁ-
cial heart valves.1 The most commonly used anticoagulant
and anti-platelet drugs include warfarin, enoxaparin, aspirin
and clopidogrel.2,3 One of the side effects of this class of drug
is that these prolong bleeding time that can cause problems
especially after surgical procedures.4,5 Due to growing cardio-
vascular disease burden, performing dental procedures on
patients who are taking oral anticoagulants is common nowa-
days. Although bleeding or haemorrhage is a frequent compli-
cation for such patients, there is controversy concerning the
change or discontinuation of anticoagulation and antiplatelet
drugs during minor dental surgery such as tooth extraction.6
The dental management of patients on anticoagulant ther-
apy is still being debated with some clinicians preferring to fol-
low the routine practice of arranging to stop anticoagulant/
anti-platelets while others prefer the continuation of anticoag-
ulant/antiplatelet therapy.6,7 The argument to stop anticoagu-
lant/antiplatelet drugs few days before a dental procedure is to
prevent potential bleeding while the argument to continue with
such medication is to concentrate more on providing careful
monitoring of patient’s International Normalized Ratio
(INR) and the use of local haemostatic measures.7 For Patients
requiring dental procedures and with signiﬁcant thromboem-
bolic events, discontinuation of warfarin could produce fatal
consequences.8 These patients can beneﬁt from bridging thera-
peutic approach to employ low molecular weight heparin or
newer anti-coagulant drugs after consultation with patient’s
physician.3,5 Therefore, dentists should be aware of their
patients’ medical condition. Appropriate preoperative assess-
ment of the patient’s medication should always be considered
to provide optimal care. In a study of Spanish students, the
overall ﬁndings showed that educational programmes about
anticoagulation should be used to improve students’
knowledge of and attitudes about this topic, especially given
the lack of standardized protocols and education at Spanish
universities.9 Salam et al. suggested that patients who are
taking warfarin and have an INR less than or equal to 4.0
can be managed in primary care practice. General dental
practitioners (GDPs) should follow published guidance, partic-
ularly for single, straightforward extractions. Many GDPs,
however, refer patients taking warfarin to their local hospital,increasing waiting times for consultation before extraction.10
For most patients undergoing simple single dental extractions,
the morbidity of potential thromboembolic events if anticoag-
ulant therapy is discontinued clearly outweighs the risk of pro-
longed bleeding.11
The overall frequency of persistent bleeding (2%) is low
when all dental procedures are considered for patients on war-
farin therapy. If considering only dental patients undergoing
extractions and implant placement, the frequency increases
to 4.8%. The results suggest that patients are at greater risk
for postoperative bleeding if concurrent medications are used
that could affect their ability to maintain a clot.12 The develop-
ment of new orally administered anticoagulant drugs over the
past few years has focused on eliminating some of the disad-
vantages associated with warfarin.13
The aims of this study were to determine the level of
knowledge and attitudes of medical and dental practitioners
regarding dental management of patients receiving anti-
coagulant and/or anti-platelet therapy.
2. Methods
A self-administered questionnaire was administered among
medical and dental practitioners. Questionnaire contained
fourteen questions. The ﬁrst section contained questions about
the demographic data including age, gender and level of edu-
cation. The second section concentrated on medical and dental
practitioner’s knowledge and approach for management of
patients on anticoagulant and/or antiplatelet therapy. Study
was conducted in various health centers and hospitals in
Riyadh and Al-Kharj cities, Saudi Arabia from January 2013
till August 2013. A total of 543 questionnaires were completed
and returned by participants.
Statistical Package for Social Sciences (SPSS version 20)
was used for data entry and analysis. Descriptive and inferen-
tial statistics were used to forecast results. Frequencies cross
tabulations and charts were used in descriptive statistics and
correlation, chi-square test and analysis of variance (ANOVA)
were used on inferential statistics.
3. Results
A total of 650 questionnaires were distributed among dental
and medical practitioners and 543 were returned complete
(response rate of 83.5%), 43.6% of the participants were
female and 56.3% were male. Most of the participants (79%)
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total number of dentists who participated in the survey was
302 as compared to 241 medical practitioners. Most of the par-
ticipants were general practitioners (59.35%), while 30.9% had
postgraduate degrees and few were holding higher degrees such
as PhD (6.4%). There was a higher percentage (58.9%) of
Medical practitioners holding postgraduate degrees as com-
pared to the dental practitioner group (41%). About 78% of
the dentists and medical practitioners had an experience in
the profession up to 10 years. However, majority among the
dental practitioner group (n= 194) had less than 5 years of
clinical experience. The overall experience was higher in the
medical practitioner group. Most of the respondents
(47.14%) represented primary level of health care. Majority
of the respondents 72.37% represented governmental institu-
tions. There was no signiﬁcant statistical difference among
gender across various opinions (Table 1).
Dentists and medical practitioners were asked about their
concern with anti-platelet agents (Aspirin and Clopidogrel)
and anti-coagulant (Warfarin). Evaluation of responses
showed that it was statistically signiﬁcant (p< 0.001) that
most dentists had concern related to aspirin (53.3%) while
medical practitioners’ main concern was warfarin (59.3%),
(Fig. 1).
The majority of dentists and medical practitioners (77.9%)
wanted to stop antiplatelet or anticoagulant drugs before any
surgical procedure like tooth extraction. More dentists
(n= 84) as compared to medical practitioners (n= 50) were
in favor to stop aspirin prior to any oral surgical procedureTable 1 Demographics of the participants with their profession.
Profession
Dentists (% age) M
Age
25–30 185(72.55) 70
31–40 79(45.4) 95
41–50 26(29.88) 61
50 + 12(44.44) 15
Gender
Male 175(57.19) 13
Female 127(53.58) 11
Highest study
Graduate 216(67.08) 10
Post Graduate 69(41.07) 99
Doctorial PhD 14(40) 21
Other 3(16.67) 15
Experience (Years)
Less than 5 198(72.53) 75
6–10 76(50.67) 74
11–15 8(13.33) 52
15+ 20(33.33) 40
Institution
Government 247 (62.84) 14
Private 55 (36.67) 95
Level of care
Primary 148 (55.26) 10
Secondary 88 (61.11) 56
Tertiary 66 (45.83) 77and the difference in opinion was statistically signiﬁcant
(Chi-square test, p= 0.001) A total of 84 (15.4%) dentists
and medical practitioners were in favor of continuing the anti-
platelet or anticoagulant medication without alteration while
6.6% were unsure whether to stop the medication or continue
its use (Fig. 2).
The percentage of dentists and medical practitioners who
prefer to ask a specialist opinion prior to such treatment
was 64.6%. Time to request blood investigation, for those
patients taking warfarin, was also asked and most of the
respondents were in favor to do the blood test within 72
hours (Table 2). More number of dental practitioners were
unaware of the proper laboratory investigation for such
patients prior to dental treatment as compared to medical
practitioners. 53% (n= 160) of dentists and 74% (n= 179)
of medical practitioners were of the opinion that INR is man-
datory before dental treatment for patients on anticoagulants.
Few dentists and medical practitioners (9.3%) were not aware
which blood test should be requested prior dental treatment
for such patients (Fig. 3).
Approach of medical practitioners, towards the use of cur-
rent guidelines in the management of patients, was signiﬁcantly
different from dentists (p< 0.001). A 28.8% of medical prac-
titioners were in favor to use current guidelines. While in den-
tists, 17.8% wanted to follow the current guidelines. Dentist
(58.6%) and medical practitioners (64.7%) felt that the evi-
dence based guidelines would be helpful in dental management
of patients on anticoagulant and/or antiplatelet therapy
(Fig. 4).Total (overall % age)
edical Practitioners (% age)
(27.45) 255(46.96)
(54.6) 174(32.04)
(70.11) 87(16.02)
(55.55) 27(4.67)
1(42.81) 306(56.35)
0(46.41) 237(43.65)
6(32.91) 322(59.3)
(58.92) 168(30.94)
(60) 35(6.44)
(83.33) 18(3.31)
(27.47) 273(50.28)
(49.33) 150(27.62)
(86.67) 60(11.05)
(66.67) 60(11.05)
6 (37.15) 393 (72.37)
(63.33) 150 (27.62)
8 (42.18) 256 (47.14)
(38.88) 144 (26.51)
(53.47) 143 (26.33)
Figure 1 Opinion of the practitioners regarding the most concerned medicine.
Figure 2 Opinion of practitioners for the medicine to be stopped before dental procedure.
Table 2 Practitioners’ approach towards the ideal time for blood investigation.
Profession Time of blood investigation Total
Within one week Within 72 h Same day Do not know
Dentist 59 133 62 48 302
Medical Practitioner 64 110 43 24 241
Total 123 243 105 72 543
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Patients who are on anticoagulant therapy and undergoing
surgical procedures may be at risk of bleeding. Growing num-
ber of evidences suggest that stopping anticoagulant therapy
before dental procedure may increase risk of thrombo-embolic
events.14,15 Different guidelines regarding how to manage such
patients before surgical interventions have been proposed in
the literature.16,17 It is clear from the results of the present
study that the subject of managing patients who are on antico-
agulant and/or antiplatelet therapy is still not a straightfor-
ward issue. Despite the availability of some guidelines, the
management of dental patients receiving anticoagulant
and/or antiplatelet therapy is still not well deﬁned.4.1. Concern for anticoagulants (Warfarin)
Although the post-operative bleeding associated with the use
of warfarin can be life threatening as compared to aspirin,18
it is obvious from our survey that dentists are more concerned
about aspirin than warfarin. The concern for aspirin rather
than warfarin among dental practitioners’, particularly general
dental practitioners, may be due to the fact that they are more
exposed to treating patients on aspirin than those on warfarin.
A high percentage (77.95) of participants in the present study
wanted to stop the anticoagulant therapy before dental proce-
dure. Fortunately though, such preference is supported by a
high percentage that would need to seek a specialist opinion
or help for such a decision. The American College of Chest
Figure 3 Opinion of practitioners for blood investigation to be requested for the patients on anticoagulant and/or antiplatelet therapy.
Figure 4 Opinion about beneﬁting from evidence based guidelines in patient management.
Knowledge of medical and dental practitioners towards dental management of patients 95Physicians suggest that patients should stop warfarin 5 days
before the surgical intervention and temporarily replacing war-
farin with low molecular weight heparin in case of extensive
surgical procedures.5,19 The American Heart Association sug-
gests reducing the INR to a range between 2.0 and 2.5 with a
strict INR monitoring.20 Many studies discuss whether to stop
or continue anticoagulant therapy when performing different
dental procedures. For instance, it has been reported that den-
tal extraction can be done safely in patients taking warfarin
providing that the INR level is below 4.0.20,21
4.2. Concern about antiplatelets (Aspirin)
The overall experience in the medical practitioner group was
higher than the dental practitioner group. Many among dental
practitioners prefer to stop aspirin before any oral surgical
procedure as compared to medical practitioners. Such varia-
tions in opinions are considered normal owing to the lack of
clear guidelines on this aspect. Moreover, dentists have beenfollowing the routine non-evidence based practice of stopping
the medication before treatment for fear of excessive post-
operative bleeding.
4.3. International Normalized Ratio (INR)
Although INR is considered a critical test in patients on anti-
coagulant therapy, only 53% of participant dental practitio-
ners and 74% of medical practitioners reported that it is a
mandatory test. This can be attributed towards lack of knowl-
edge among dentists as compared to medical practitioners
about the investigations needed for patients on warfarin.
Working with patients who are taking anticoagulants without
measuring their INR could lead to major complications.18
Timing of INR is also important as its values may vary dras-
tically if it is not measured within the recommended duration.
Guidelines state that INR of patients should be measured
within 72 h before oral surgery or ideally within 24 h.22
Regarding the ideal timing for blood investigation a high
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earlier (same day), prior to the dental procedure. Blood
investigations may be invalid at the time of the dental appoint-
ment especially with INR that could be at a different level and
could lead to serious consequences. It has been stated that non
adherence of INR monitoring for patients on anticoagulant
therapy can be associated with high risk of bleeding.23
4.4. Evidence based guidelines
For medical conditions like; atrial ﬁbrillation, pulmonary
embolism etc. patients are placed on anticoagulant (commonly
on warfarin) in order to prevent any consequences.24 During
the era of 1940–1980, Dentists and authors had perception that
patients on warfarin often have prolonged bleeding and adjust-
ment of warfarin regime was required before invasive dental
treatment.25,26 However, recent literature regarding warfarin
and dental surgery, added the knowledge that normal oral
surgical procedures can be performed without the need for
alteration of the anticoagulant dose.7 In 2007, British Commit-
tee for standards in Haematology (BCSH) together with
British Dental Association and National Patient Safety
Agency prepared a guideline for managing patients on
warfarin. The guidelines state that patients, on warfarin with
stable INR of 64, have very small risk of signiﬁcant bleed-
ing.15,22 In-spite of the presence of such guidelines in the
literature, it is still difﬁcult especially for dentists to follow
such guidelines. In the present study a little percentage among
dentists (17.8%) and medical practitioners (28.8%) were fol-
lowing these guidelines. Such hesitation in following guidelines
shows that the management of patients on anticoagulant
therapy still needs more clariﬁcation for practitioners. One of
the reasons may be, to follow a routine method of practice
rather than an Evidence Based Health care practice.
Educational programs or workshops related to the subject
can increase the awareness of practitioners to update their
knowledge and practice related to managing patients on
anticoagulant therapy prior to dental treatment.17
However, there are some situations in which patients’ man-
agement becomes quite difﬁcult. For instance, when patients
are taking both warfarin and anti-platelet agents, when patient
has a disease that modiﬁes pharmacokinetics of warfarin or
when a patient has a bleeding disorder.27 Therefore it is advis-
able that any patient with complicated medical history and
warfarin treatment and multiple medications should be treated
under special conditions.16,28
The present study had some limitations such as the partic-
ipants/practitioners were from only two cities (Riyadh and
Al-Kharj). There is some discrepancy among certain groups
like more number of graduate dental practitioners as com-
pared to general medical practitioners. Surveying more cities
in the kingdom of Saudi Arabia and increasing the sample size
will give a better understanding of the current knowledge and
awareness of practitioners in the management of patients on
anticoagulant and/or antiplatelet therapy.
5. Conclusion
In this study, both dentists and medical practitioners showed
wide range of approach in terms of dental management of
anti-coagulated patients. The ﬁndings conﬁrm use of
traditional or routine practice of dental management for suchpatients rather than evidence based practice. The ﬁnding from
current study suggests that there is a great need to educate
both medical and dental practitioners to use evidence based
guidelines in terms of dental treatment for patients on antico-
agulant and/or antiplatelet therapy.
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